FDA approves Ultragenyx’s gene therapy Genglycos for glycogen storage disordernews2026-08-20T11:15:18+00:00August 20th, 2026|Endpoints News|
For Moderna, cancer vaccine results ease investor skepticism on its future as stock soarsnews2026-08-19T18:58:48+00:00August 19th, 2026|Endpoints News|
FDA approves Regeneron’s garetosmab for disease that turns tissue to bonenews2026-08-19T18:42:46+00:00August 19th, 2026|Endpoints News|
FDA pick Heidi Overton has been critical of vaccine requirements, abortion pillsnews2026-08-19T18:21:29+00:00August 19th, 2026|Endpoints News|
Analysis: What Anthropic’s protein study says about its life sciences aimsnews2026-08-19T15:21:00+00:00August 19th, 2026|Endpoints News|
Amylin design debate heats up as Lilly’s crucial mid-stage weight loss data nearnews2026-08-19T14:52:57+00:00August 19th, 2026|Endpoints News|
Amgen cans its TScan partnership; Amylyx reveals $350M offeringnews2026-08-19T14:43:16+00:00August 19th, 2026|Endpoints News|
Bristol Myers’ partner Biokin says bispecific ADC clears fourth cancer trial in Chinanews2026-08-19T11:05:05+00:00August 19th, 2026|Endpoints News|
Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccinenews2026-08-19T10:45:01+00:00August 19th, 2026|Endpoints News|
Federal appeals court revives part of Teva’s IRA case as Austedo price cuts loomnews2026-08-19T06:22:29+00:00August 19th, 2026|Endpoints News|
